News Contact Us

Breast Cancer Therapeutics Market 2020 by industry trends, statistics, key companies growth and regional forecast

Author : Ronak Bora | Published Date : 2020-09-17 

Breast Cancer Therapeutics Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.

Breast cancer is the most frequent form of cancer among women, constituting a substantial percentage of cancer-associated deaths. Women diagnosed with breast cancer have numerous treatment options including hormone therapy, chemotherapy, radiation therapy, targeted drug therapy, and surgery.

Novartis AG, Pfizer, AstraZeneca, Eisai Co. Ltd., Teva Pharmaceutical, Celgene, Roche Diagnostics, Eli Lilly, and Sanofi are a few notable breast cancer therapeutics companies. In July 2020, Novartis’ new advanced breast cancer drug Piqray gained approval from European Union regulators. The drug was approved in 2019 across the U.S. and is on sale in several other countries including Canada, Australia, and Switzerland.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/466

According to a new research report by GMI, global breast cancer therapeutics market size will be worth more than US$30.63 billion by 2025.

Developed countries including the U.S. have experienced one of the highest growths in the number of breast cancer cases in recent years. In 2017, nearly 252,710 new cases of invasive and more than 63,410 cases of non-invasive breast cancer were estimated to be detected. Meanwhile, in developing countries, growing adoption of a western lifestyle is proving to be one of the leading causes of breast cancer among women.

The management of surging breast cancer therapeutics costs driven by both price and quantity of targeted drugs is extremely challenging. Government and welfare organizations across the globe have introduced numerous insurance and reimbursement policies to ensure wider availability of anticancer drugs.

Different types of breast cancer therapeutic products and services include targeted drug therapy, hormone drugs, and chemotherapy drugs. In 2018, targeted drug therapy market was estimated to be worth nearly US$11.6 billion. Ongoing research and development efforts by industry participants will certainly enhance the effectiveness of future targeted breast cancer therapeutics solutions.

Hospitals, clinics, ambulatory surgical centers, retail pharmacies, and ecommerce are among the different channels for distribution of anticancer drugs. The distribution of breast cancer therapeutics via retail pharmacies is projected to witness a CAGR of 9.7% through 2025. A vast majority of consumers are switching to retail pharmacies on account of prolonged usage of targeted drug therapies and reimbursement variations.

China has invested substantially in upgrading and improving its healthcare infrastructure for better diagnosis and treatment of breast cancer. China breast cancer therapeutics industry size will grow at a CAGR of 13.7% through 2025. Robust economic growth, increased household income levels, a rising prevalence of breast cancer, and the availability of favorable insurance and reimbursement policies will undeniably complement the regional outlook.

With the rising cost burden associated with breast cancer, Germany has made substantial healthcare investments over the past few years. In 2014, the country’s healthcare expenditure accounted for 11.3% of its GDP. Germany dominated Europe breast cancer therapeutics industry in 2018, capturing a revenue share of around US$1.32 billion. The presence of several prominent therapy providers in the country will augment the regional market trends.

Excessive costs of breast cancer treatments, especially for patients that are not covered by insurance, may restrict the industry forecast to some extent. However, the introduction of supportive insurance and reimbursement policies will bolster breast cancer therapeutics industry outlook. 

Browse full table of contents (TOC) of this report @ https://www.gminsights.com/toc/detail/breast-cancer-therapeutics-market

Partial Chapter of the Table of Content 

Chapter 4. Breast Cancer Therapeutics Market, By Product

4.1. Global breast cancer therapeutics market share by product, 2018 & 2025

4.2. Hormone drugs

4.2.1. Market size, by region, 2014 – 2025 (USD Million)

4.3. Chemotherapy drugs

4.3.1. Market size, by region, 2014 – 2025 (USD Million)

4.4. Targeted drug therapy

4.4.1. Market size, by region, 2014 – 2025 (USD Million)

Chapter 5. Breast cancer therapeutics Market, By Distribution channel

5.1. Global breast cancer therapeutics market share by distribution channel, 2018 & 2025

5.2. Hospitals

5.2.1. Market size, by region, 2014 – 2025 (USD Million)

5.3. Ambulatory Surgical Centers

5.3.1. Market size, by region, 2014 – 2025 (USD Million)

5.4. Clinics

5.4.1. Market size, by region, 2014 – 2025 (USD Million)

5.5. e-commerce

5.5.1. Market size, by region, 2014 – 2025 (USD Million)

5.6. Retail pharmacies

5.6.1. Market size, by region, 2014 – 2025 (USD Million)

About Author

Ronak Bora

Ronak Bora

A graduate in Electronics Engineering, Ronak writes for fractovia and carries a rich experience in digital marketing, exploring how the online world works from a technical and marketing perspective. His other areas of interest include reading, music, and sport. [email protected] | https://twitter.com/RonakBora26

Related News

North America Aerospace Avionics Market to gain traction by 2025

Published Date: 2020-11-27         Author: Ronak Bora

The study on North America Aerospace Avionics Market provides a complete view on the industry with intricate details subject to its overall stance in the global landscape along with specifying various applications across major end-user sectors. North America aerospace avionics industry, as per the g... Read More

North America Aerospace Avionics Market to gain traction by 2025

Published Date: 2020-11-27         Author: Ronak Bora

... Read More

North America Biogas Market to amass significant gains by 2025

Published Date: 2020-11-27         Author: Ronak Bora

The market analysis on North America Biogas Market provides a holistic view on the overall industry along with laying significant focus on crucial details pertaining to its foothold in the global economy and its applications across multiple end-user industries and sectors. According to the given rep... Read More

© 2020 Fractovia. All Rights Reserved